Skip to main content
Home
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Chile
  • China
  • Colombia
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Netherlands
  • South Africa
  • Spain
  • Switzerland
  • Taiwan
  • United Kingdom
  • USA
  • Contact
  • English
  • French
GBT €8.96
  • Our Group
    • Guerbet in a nutshell
    • Our Corporate Responsibilities
    • Corporate Governance
    • Intrasense and Guerbet
      • Intrasense, a Guerbet Group subsidiary: Innovating in AI together
    • Careers
  • Products & Solutions
    MRI
    • Home of MRI Innovations
    • Artirem®
    • Dotarem®
    • Elucirem™ (Gadopiclenol)
    • Injectors, Accessories & Consumables
    • MRI Accessories
    • Consumables for Diagnostic Imaging
    • OptiStar® Elite
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    CT
    • Home of MRI Innovations
    • Conray® / Cysto-Conray®
    • Micropaque® / Microtrast®
    • Optiray®
    • Telebrix® Gastro
    • Xenetix® / ScanBag® by Xenetix®
    • Injectors, Accessories & Consumables
    • Consumables for Diagnostic Imaging
    • OptiBolus®
    • OptiOne™
    • OptiVantage™ Multi-use
    • OptiVantage™ Single-use
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    Cath Lab
    • Home of MRI Innovations
    • Optiray®
    • Xenetix® / ScanBag® by Xenetix®
    • Injectors, Accessories & Consumables
    • Consumables for Diagnostic Imaging
    • Illumena® Néo
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    Interventional Radiology
    • Pharmaceutical Drugs
    • Lipiodol® Ultra Fluid
    • Medical Devices
    • Qitexio®
    Solutions d’imagerie interventionnelle

    Interventional Imaging Solutions

    Explore our Solutions
    Women's Health
    • Pharmaceutical Drugs
    • Patent Blue V
    • Lipiodol® Ultra Fluid
    Fertility and women's health

    Women’s Health

    Explore our Solutions
  • Investors
    • Key Figures
    • Stock Performance
    • Financial Policy
    • Presentations, Reports & Regulated information
    • Agenda
    • General Meetings
  • Media
  • Educational Resources
  • Patient Resources
    • Blue November
    • Liver Cancer Awareness Month
    • Osteoarthritis
    • Vascular embolization
  • 100 years
    • Celebrating 100 years
    • Guerbet Saga

Media

Welcome to Guerbet Media section for journalists. The press releases are intended for their professional use. Find our latest press releases and our media resources.

Media…
  1. Homepage
  2. Media

Our Latest Press Releases

Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT

Read the article

Changes to the Composition of Guerbet’s Board of Directors

Read the article

Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)

Read the article
Webinar: Leveraging Artificial Intelligence in a COVID-19 Environment

Guerbet To Sell Its Urological Imaging Systems Business Assets To Del Medical

Read the article
2023年第1四半期 収益報告

Q1 2024 revenue

Read the article
2023 full-year results

2023 full-year results

Read the article
David Hale appointed CEO of Guerbet as from January 1, 2020 to accelerate deployment of the Group’s strategy

Change in Guerbet’s Board of Directors

Read the article
Organization Announcement Executive Committee

Organization Announcement Executive Committee

Read the article
Guerbet Launch Solar Project to Power 18% of Pharmaceutical Operations in Dublin

Guerbet Launch Solar Project to Power 18% of Pharmaceutical Operations in Dublin

Read the article

Michel Guerbet, a historic and iconic figure of the Group passed away

Read the article
Intrasense abre su capital social al Grupo Guerbet, que anuncia su intención de presentar una oferta…

Guerbet strengthens its Executive Committee with two new appointments to accelerate its commercial and industrial development

Read the article
Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer

Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer

Read the article
  • ‹
  • 1
  • 2
  • 3
  • Current page4
  • 5
  • 6
  • 7
  • 8
  • 9
  • ›
Image
Logo Guerbet
  • Legal Information
  • Cookie Policy
  • Data Protection Policy
  • Patents
  • Contact
Copyright © Guerbet
2026
  • LinkedIn
  • Twitter
  • Instagram
  • YouTube